| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | organelle localization | TLK2 MYO1C RB1 CENPF CCDC186 SYNE1 IKBKG MYLK2 SPDL1 CFHR4 CEP63 MDN1 BRCA2 SEC16A EXOC1 ZW10 ATP2A2 EXOC4 | 9.66e-09 | 703 | 102 | 18 | GO:0051640 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYO1C RB1 CENPF CCDC186 SYNE1 IKBKG MYLK2 SPDL1 CEP63 MDN1 BRCA2 SEC16A EXOC1 ZW10 EXOC4 | 7.60e-08 | 546 | 102 | 15 | GO:0051656 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ROCK2 TMEM67 CNTRL SIK3 ODF2 SPDL1 CEP63 CCDC88C NCOR1 HAUS4 BRCA2 CGN SSX2IP ZW10 PHLDB2 KIF11 | 4.77e-07 | 720 | 102 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | centrosome cycle | 1.57e-06 | 164 | 102 | 8 | GO:0007098 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 3.01e-06 | 179 | 102 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | chromosome segregation | TLK2 RB1 CENPF SPDL1 CEP63 NCOR1 HAUS4 BRCA2 ZW10 TOP2B KIF11 | 1.91e-05 | 465 | 102 | 11 | GO:0007059 |
| GeneOntologyBiologicalProcess | cell cycle process | ROCK2 TLK2 TMEM67 RB1 CENPF SIN3A ODF2 ESCO1 SPDL1 CEP63 NCOR1 HAUS4 BRCA2 ZFP36L2 SSX2IP EXOC1 ZW10 TOP2B KIF11 EXOC4 | 2.22e-05 | 1441 | 102 | 20 | GO:0022402 |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 3.21e-05 | 122 | 102 | 6 | GO:0051303 | |
| GeneOntologyBiologicalProcess | cell division | ROCK2 RB1 CENPF CNTRL SPDL1 CEP63 HAUS4 BRCA2 ZFP36L2 EXOC1 ZW10 KIF11 EXOC4 | 3.95e-05 | 697 | 102 | 13 | GO:0051301 |
| GeneOntologyBiologicalProcess | organelle assembly | TMEM67 MYH11 CENPF SYNE1 CNTRL RB1CC1 ODF2 CC2D2B CEP63 NCOR1 ODF2L HAUS4 MDN1 SSX2IP ATP2A2 CCDC136 KIF11 | 4.05e-05 | 1138 | 102 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | chromosome localization | 4.58e-05 | 130 | 102 | 6 | GO:0050000 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 TMEM67 CNTRL SIK3 ODF2 SPDL1 CEP63 CCDC88C NCOR1 HAUS4 BRCA2 CGN SSX2IP ZW10 PHLDB2 KIF11 | 6.08e-05 | 1058 | 102 | 16 | GO:0007017 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MORC1 TLK2 MBD3L1 RAG2 SETD1B MYO1C RB1 CENPF SIN3A TFAP2C NCOR1 BRCA2 MCM3AP ATF7IP2 MYOCD | 1.15e-04 | 999 | 102 | 15 | GO:0071824 |
| GeneOntologyBiologicalProcess | establishment of vesicle localization | 1.25e-04 | 224 | 102 | 7 | GO:0051650 | |
| GeneOntologyBiologicalProcess | chromatin organization | MORC1 TLK2 MBD3L1 RAG2 SETD1B MYO1C RB1 SIN3A TFAP2C NCOR1 BRCA2 MCM3AP ATF7IP2 MYOCD | 1.31e-04 | 896 | 102 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromosome organization | RB1 CENPF ESCO1 SPDL1 DHX9 CEP63 BRCA2 ATF7IP2 NAV2 ZW10 TOP2B KIF11 | 1.46e-04 | 686 | 102 | 12 | GO:0051276 |
| GeneOntologyBiologicalProcess | metaphase chromosome alignment | 1.91e-04 | 107 | 102 | 5 | GO:0051310 | |
| GeneOntologyBiologicalProcess | vesicle localization | 2.28e-04 | 247 | 102 | 7 | GO:0051648 | |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 2.42e-04 | 421 | 102 | 9 | GO:0010639 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 2.50e-04 | 177 | 102 | 6 | GO:0030010 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 2.85e-04 | 64 | 102 | 4 | GO:0010965 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.90e-04 | 257 | 102 | 7 | GO:0007163 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ROCK2 TMEM67 MYO1C RB1 CENPF SYNE1 SPTA1 ODF2 SPDL1 CCDC88C ODF2L HAUS4 SSH1 ATF7IP2 SEC16A ZW10 PHLDB2 | 2.98e-04 | 1342 | 102 | 17 | GO:0033043 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 3.40e-04 | 67 | 102 | 4 | GO:0051306 | |
| GeneOntologyBiologicalProcess | intracellular transport | RANBP2 MYO1C COPB1 CCDC186 SYNE1 MYLK2 DHX9 EPG5 WDR91 CCDC88C MDN1 ERGIC3 MCM3AP SSX2IP SEC16A ZW10 ATP2A2 EXOC4 | 3.63e-04 | 1496 | 102 | 18 | GO:0046907 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 3.90e-04 | 356 | 102 | 8 | GO:0098813 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 4.36e-04 | 362 | 102 | 8 | GO:0010948 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 4.92e-04 | 464 | 102 | 9 | GO:0045786 | |
| GeneOntologyCellularComponent | spindle pole | 7.33e-07 | 205 | 102 | 9 | GO:0000922 | |
| GeneOntologyCellularComponent | spindle | ROCK2 RB1 CENPF CNTRL IKBKG ODF2 SPDL1 CEP63 NCOR1 HAUS4 ZW10 KIF11 | 3.21e-06 | 471 | 102 | 12 | GO:0005819 |
| GeneOntologyCellularComponent | centrosome | ROCK2 TMEM67 CENPF CNTRL ANKRD26 ODF2 SPDL1 DHX9 CEP63 CCDC88C ODF2L HAUS4 BRCA2 SSX2IP EXOC4 | 4.82e-06 | 770 | 102 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | ROCK2 TMEM67 DLG5 CENPF CNTRL ANKRD26 ODF2 SPDL1 DHX9 CEP63 CCDC88C ODF2L HAUS4 BRCA2 SSX2IP EXOC4 | 9.33e-06 | 919 | 102 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | Flemming body | 7.16e-04 | 36 | 102 | 3 | GO:0090543 | |
| GeneOntologyCellularComponent | midbody | 7.73e-04 | 222 | 102 | 6 | GO:0030496 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.03e-03 | 10 | 102 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 1.03e-03 | 10 | 102 | 2 | GO:0120103 | |
| MousePheno | abnormal embryonic growth/weight/body size | TLK2 DLG5 SETD1B RB1 CCDC186 LGR4 REV3L RB1CC1 TFAP2C BRAP WDR91 NCOR1 HAUS4 BRCA2 AMOT CGN MYOCD ATP2A2 TOP2B KIF11 EXOC4 | 5.38e-06 | 1295 | 78 | 21 | MP:0002088 |
| MousePheno | abnormal embryo development | TLK2 EHBP1 TMEM67 DLG5 RANBP2 SETD1B RB1 CCDC186 LGR4 REV3L RB1CC1 TFAP2C BRAP DHX9 HAUS4 BRCA2 AMOT MYOCD TOP2B KIF11 EXOC4 | 1.29e-05 | 1370 | 78 | 21 | MP:0001672 |
| MousePheno | abnormal prenatal growth/weight/body size | TLK2 DLG5 SETD1B RB1 CCDC186 CNTRL LGR4 REV3L RB1CC1 TFAP2C BRAP WDR91 NCOR1 HAUS4 BRCA2 AMOT CGN MYOCD ATP2A2 TOP2B KIF11 EXOC4 | 1.41e-05 | 1493 | 78 | 22 | MP:0004196 |
| MousePheno | neonatal lethality, incomplete penetrance | 4.05e-05 | 298 | 78 | 9 | MP:0011088 | |
| MousePheno | embryonic growth retardation | DLG5 SETD1B RB1 CCDC186 LGR4 REV3L RB1CC1 TFAP2C BRAP HAUS4 BRCA2 AMOT MYOCD TOP2B | 7.27e-05 | 763 | 78 | 14 | MP:0003984 |
| MousePheno | increased nucleated erythrocyte cell number | 1.33e-04 | 47 | 78 | 4 | MP:0009395 | |
| MousePheno | abnormal nucleated erythrocyte cell number | 1.57e-04 | 49 | 78 | 4 | MP:0012397 | |
| Domain | Odf2-rel | 2.78e-05 | 2 | 99 | 2 | IPR026099 | |
| Domain | HATPase_c | 1.11e-04 | 18 | 99 | 3 | SM00387 | |
| Domain | HATPase_c | 1.32e-04 | 19 | 99 | 3 | PF02518 | |
| Domain | - | 1.54e-04 | 20 | 99 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 1.79e-04 | 21 | 99 | 3 | IPR003594 | |
| Domain | Myosin_tail_1 | 4.03e-03 | 18 | 99 | 2 | PF01576 | |
| Domain | Myosin_tail | 4.03e-03 | 18 | 99 | 2 | IPR002928 | |
| Domain | CH | 4.97e-03 | 65 | 99 | 3 | SM00033 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.11e-05 | 204 | 74 | 8 | M4217 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 8.66e-05 | 201 | 74 | 7 | M27472 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 8.93e-05 | 202 | 74 | 7 | MM15362 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 1.54e-04 | 97 | 74 | 5 | M27478 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.59e-04 | 297 | 74 | 8 | M27050 | |
| Pathway | REACTOME_CELL_CYCLE | RANBP2 RB1 CENPF SYNE1 CNTRL ODF2 ESCO1 SPDL1 CEP63 HAUS4 BRCA2 ZW10 | 2.44e-04 | 694 | 74 | 12 | M543 |
| Pathway | REACTOME_M_PHASE | 3.21e-04 | 417 | 74 | 9 | M27662 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ROCK2 DLG5 RANBP2 MYH11 CENPF ANKRD26 PREX2 SPDL1 WDR91 SRGAP1 ZW10 GOLGA3 | 3.41e-04 | 720 | 74 | 12 | M41838 |
| Pubmed | EHBP1 RANBP2 CENPF IKBKG RB1CC1 SPDL1 NCOR1 BRCA2 AMOT ATF7IP2 SEC16A GOLGA3 KIF11 EXOC4 | 3.15e-11 | 418 | 104 | 14 | 34709266 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 DLG5 ANKRD26 SIK3 MYLK2 ARFGEF3 CCDC88C MDN1 ZFP36L2 AMOT SRGAP1 CGN SSX2IP SEC16A NAV2 PHLDB2 KIF11 EXOC4 | 9.25e-11 | 861 | 104 | 18 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ROCK2 TLK2 RANBP2 MYO1C SIN3A ODF2 DHX9 FBXO38 NCOR1 MDN1 SSH1 SEC16A ATP2A2 TOP2B PHLDB2 | 1.08e-08 | 774 | 104 | 15 | 15302935 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DLG5 SETD1B RB1 ANKRD26 BRAP ARFGEF3 NCOR1 ODF2L HAUS4 BRCA2 MCM3AP SEC16A EXOC4 | 2.43e-08 | 588 | 104 | 13 | 38580884 |
| Pubmed | ROCK2 TLK2 RANBP2 CENPF SYNE1 WDR18 SIK3 WDR91 CCDC88C NCOR1 MDN1 SSH1 SEC16A GOLGA3 PHLDB2 KIF11 | 2.87e-08 | 963 | 104 | 16 | 28671696 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 RANBP2 CNTRL ANKRD26 WDR18 SIK3 ODF2 CCDC88C NCOR1 ODF2L HAUS4 BRCA2 CGN SSX2IP EXOC4 | 3.89e-08 | 853 | 104 | 15 | 28718761 |
| Pubmed | ROCK2 RANBP2 MYH11 MYO1C CENPF SPOCK1 SYNE1 KRT84 SPTA1 CNTRL ANKRD26 ODF2 MYLK2 NCOR1 MDN1 NAV2 ATP2A2 TOP2B KIF11 | 5.07e-08 | 1442 | 104 | 19 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 COPB1 CENPF KRT82 SYNE1 KRT84 WDR18 RB1CC1 DHX9 MDN1 AMOT CGN SEC16A ATP2A2 TOP2B PHLDB2 | 6.67e-08 | 1024 | 104 | 16 | 24711643 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH11 MYO1C COPB1 SPOCK1 SYNE1 SPTA1 CNTRL DHX9 EPG5 FSD1L CLEC4F MDN1 MYOCD ATP2A2 | 1.36e-07 | 807 | 104 | 14 | 30575818 |
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 12466959 | ||
| Pubmed | ROCK2 EHBP1 MYH11 ANKRD26 ESCO1 CCDC88C SSH1 SOCS5 CGN SSX2IP EXOC4 | 2.83e-07 | 493 | 104 | 11 | 15368895 | |
| Pubmed | DLG5 RB1 ANKRD26 ODF2 ODF2L HAUS4 AMOT SSX2IP SEC16A EXOC1 KIF11 EXOC4 | 5.47e-07 | 645 | 104 | 12 | 25281560 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 7.40e-07 | 104 | 104 | 6 | 31240132 | |
| Pubmed | Planar cell polarity induces local microtubule bundling for coordinated ciliary beating. | 9.01e-07 | 7 | 104 | 3 | 33929515 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 9.83e-07 | 344 | 104 | 9 | 36282215 | |
| Pubmed | 1.59e-06 | 187 | 104 | 7 | 26460568 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TLK2 RANBP2 COPB1 CENPF SYNE1 WDR18 ESCO1 DHX9 CEP63 FBXO38 ODF2L HAUS4 ZW10 TOP2B EXOC4 | 1.81e-06 | 1155 | 104 | 15 | 20360068 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.22e-06 | 208 | 104 | 7 | 33230847 | |
| Pubmed | RANBP2 COPB1 WDR18 SIN3A DHX9 MDN1 ZW10 ATP2A2 TOP2B KIF11 EXOC4 | 3.47e-06 | 638 | 104 | 11 | 33239621 | |
| Pubmed | MYO1C COPB1 CCDC186 CNTRL ANKRD26 LGR4 DHX9 ARFGEF3 NCOR1 AMOT SEC16A GOLGA3 | 3.76e-06 | 777 | 104 | 12 | 35844135 | |
| Pubmed | 4.94e-06 | 222 | 104 | 7 | 37071664 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 5.34e-06 | 146 | 104 | 6 | 23892456 | |
| Pubmed | 5.34e-06 | 146 | 104 | 6 | 21399614 | ||
| Pubmed | 6.48e-06 | 151 | 104 | 6 | 17043677 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 6.60e-06 | 87 | 104 | 5 | 17148452 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15861132 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 11788883 | ||
| Pubmed | RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells. | 8.86e-06 | 2 | 104 | 2 | 14533007 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19009954 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7651420 | ||
| Pubmed | Isolation, characterization and mapping of the mouse and human RB1CC1 genes. | 8.86e-06 | 2 | 104 | 2 | 12095676 | |
| Pubmed | 55-year-old woman with menopausal symptoms and a family history of breast cancer. | 8.86e-06 | 2 | 104 | 2 | 18380995 | |
| Pubmed | CMF1-Rb interaction promotes myogenesis in avian skeletal myoblasts. | 8.86e-06 | 2 | 104 | 2 | 18425850 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7542657 | ||
| Pubmed | Expression and regulation of RB1CC1 in developing murine and human tissues. | 8.86e-06 | 2 | 104 | 2 | 15375585 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 27742670 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ROCK2 TLK2 EHBP1 RB1 DHX9 HAUS4 ZFP36L2 AMOT CGN CCDC154 SEC16A EXOC1 ZW10 PHLDB2 EXOC4 | 9.15e-06 | 1321 | 104 | 15 | 27173435 |
| Pubmed | RANBP2 GALNT1 MYO1C COPB1 CNTRL DHX9 NCOR1 MDN1 ERGIC3 EXOC1 ZW10 GOLGA3 KIF11 EXOC4 | 1.02e-05 | 1168 | 104 | 14 | 19946888 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 SETD1B MYO1C COPB1 RB1 DHX9 MDN1 MCM3AP SEC16A EXOC1 ATP2A2 TOP2B PHLDB2 KIF11 EXOC4 | 1.21e-05 | 1353 | 104 | 15 | 29467282 |
| Pubmed | 1.23e-05 | 169 | 104 | 6 | 31462741 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.25e-05 | 256 | 104 | 7 | 33397691 | |
| Pubmed | 1.49e-05 | 263 | 104 | 7 | 34702444 | ||
| Pubmed | 1.60e-05 | 486 | 104 | 9 | 20936779 | ||
| Pubmed | 1.71e-05 | 17 | 104 | 3 | 21241894 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.88e-05 | 182 | 104 | 6 | 32239614 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RANBP2 MYH11 MYO1C COPB1 ITGA2 MDN1 SEC16A ZW10 ATP2A2 EXOC4 | 2.52e-05 | 647 | 104 | 10 | 26618866 |
| Pubmed | Regulation of Hoxa2 in cranial neural crest cells involves members of the AP-2 family. | 2.65e-05 | 3 | 104 | 2 | 10068641 | |
| Pubmed | RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients. | 2.65e-05 | 3 | 104 | 2 | 21203526 | |
| Pubmed | A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. | 2.65e-05 | 3 | 104 | 2 | 9139820 | |
| Pubmed | RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. | 2.65e-05 | 3 | 104 | 2 | 35179959 | |
| Pubmed | Sec3-containing exocyst complex is required for desmosome assembly in mammalian epithelial cells. | 2.65e-05 | 3 | 104 | 2 | 19889837 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 21084279 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11420704 | ||
| Pubmed | Rb1cc1 is critical for myoblast differentiation through Rb1 regulation. | 2.65e-05 | 3 | 104 | 2 | 15968549 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 2431943 | ||
| Pubmed | RANBP2 MYO1C COPB1 CENPF WDR18 MDN1 MCM3AP CGN SEC16A ATP2A2 | 2.72e-05 | 653 | 104 | 10 | 22586326 | |
| Pubmed | 2.85e-05 | 20 | 104 | 3 | 27773593 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.93e-05 | 197 | 104 | 6 | 20811636 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 3.15e-05 | 120 | 104 | 5 | 31413325 | |
| Pubmed | 3.32e-05 | 21 | 104 | 3 | 24923560 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.37e-05 | 202 | 104 | 6 | 33005030 | |
| Pubmed | 3.37e-05 | 202 | 104 | 6 | 24639526 | ||
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 3.59e-05 | 302 | 104 | 7 | 30561431 | |
| Pubmed | PMS1 DLG5 EARS2 SYNE1 ANKRD26 SIK3 RB1CC1 BRAP DHX9 MDN1 SSX2IP ATP2A2 GOLGA3 TOP2B EXOC4 | 3.63e-05 | 1487 | 104 | 15 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | EHBP1 NEMP1 MYO1C CENPF EARS2 SYNE1 DHX9 ARFGEF3 MDN1 SSX2IP SEC16A ZW10 ATP2A2 GOLGA3 EXOC4 | 3.89e-05 | 1496 | 104 | 15 | 32877691 |
| Pubmed | 4.03e-05 | 421 | 104 | 8 | 36976175 | ||
| Pubmed | 4.18e-05 | 64 | 104 | 4 | 22865885 | ||
| Pubmed | 4.19e-05 | 210 | 104 | 6 | 16565220 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 5.02e-05 | 217 | 104 | 6 | 31685992 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 10441327 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 19885391 | ||
| Pubmed | Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. | 5.29e-05 | 4 | 104 | 2 | 10791974 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 11306549 | ||
| Pubmed | Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. | 5.29e-05 | 4 | 104 | 2 | 9139821 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 32655569 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 9497340 | ||
| Pubmed | TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. | 5.29e-05 | 4 | 104 | 2 | 11439334 | |
| Pubmed | The Ski protein family is required for MeCP2-mediated transcriptional repression. | 5.29e-05 | 4 | 104 | 2 | 11441023 | |
| Pubmed | RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer. | 5.29e-05 | 4 | 104 | 2 | 20614030 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 19596800 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 31806642 | ||
| Pubmed | LEK1 is a potential inhibitor of pocket protein-mediated cellular processes. | 5.29e-05 | 4 | 104 | 2 | 14555653 | |
| Pubmed | ROCK2 EHBP1 DLG5 RANBP2 COPB1 ANKRD26 DHX9 SEC16A ATP2A2 EXOC4 | 5.37e-05 | 708 | 104 | 10 | 39231216 | |
| Pubmed | 5.39e-05 | 568 | 104 | 9 | 37774976 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ROCK2 DLG5 RANBP2 RNMT MYO1C COPB1 WDR18 SIN3A BRAP SEC16A EXOC1 ATP2A2 PHLDB2 KIF11 | 5.75e-05 | 1367 | 104 | 14 | 32687490 |
| Pubmed | FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates. | 5.84e-05 | 223 | 104 | 6 | 34226595 | |
| Pubmed | 6.04e-05 | 446 | 104 | 8 | 24255178 | ||
| Pubmed | 6.14e-05 | 225 | 104 | 6 | 12168954 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 6.49e-05 | 582 | 104 | 9 | 20467437 | |
| Pubmed | PMS1 RANBP2 MYO1C RB1CC1 ODF2 FBXO38 NCOR1 SSH1 CGN SSX2IP SEC16A ATP2A2 | 7.20e-05 | 1049 | 104 | 12 | 27880917 | |
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 7.21e-05 | 27 | 104 | 3 | 18649358 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 7.80e-05 | 235 | 104 | 6 | 28378594 | |
| Pubmed | 8.17e-05 | 237 | 104 | 6 | 29564676 | ||
| Pubmed | 8.57e-05 | 469 | 104 | 8 | 27634302 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 16227606 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 2895697 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 17287852 | ||
| Pubmed | Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells. | 8.80e-05 | 5 | 104 | 2 | 15729358 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 18541705 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 12634383 | ||
| Interaction | NDC80 interactions | ROCK2 DLG5 RB1 ANKRD26 ODF2 CEP63 ODF2L HAUS4 AMOT SSX2IP EXOC1 ZW10 CCDC136 GOLGA3 PHLDB2 EXOC4 | 3.63e-12 | 312 | 101 | 16 | int:NDC80 |
| Interaction | CEP135 interactions | DLG5 ANKRD26 ODF2 CEP63 CCDC88C ODF2L HAUS4 TXLNB BRCA2 CGN SSX2IP SEC16A PHLDB2 | 1.05e-09 | 272 | 101 | 13 | int:CEP135 |
| Interaction | KDM1A interactions | EHBP1 DLG5 RANBP2 RB1 CENPF IKBKG SIN3A RB1CC1 ESCO1 TFAP2C SPDL1 NCOR1 BRCA2 AMOT SSX2IP ATF7IP2 SEC16A EXOC1 GOLGA3 KIF11 EXOC4 | 6.70e-09 | 941 | 101 | 21 | int:KDM1A |
| Interaction | MED4 interactions | DLG5 MYH11 CNTRL ANKRD26 ODF2 CEP63 ODF2L HAUS4 TXLNB AMOT SSX2IP ATF7IP2 EXOC1 KIF11 EXOC4 | 6.98e-09 | 450 | 101 | 15 | int:MED4 |
| Interaction | WHAMMP3 interactions | 8.51e-09 | 119 | 101 | 9 | int:WHAMMP3 | |
| Interaction | KRT19 interactions | DLG5 KRT82 KRT84 ANKRD26 RB1CC1 CEP63 ODF2L HAUS4 AMOT SSX2IP EXOC4 | 1.73e-07 | 282 | 101 | 11 | int:KRT19 |
| Interaction | CCDC14 interactions | 2.78e-07 | 129 | 101 | 8 | int:CCDC14 | |
| Interaction | CEP128 interactions | DLG5 CNTRL ANKRD26 ODF2 CEP63 ODF2L HAUS4 AMOT SSX2IP PHLDB2 EXOC4 | 2.90e-07 | 297 | 101 | 11 | int:CEP128 |
| Interaction | YWHAH interactions | EHBP1 DLG5 MYH11 CNTRL ANKRD26 SIK3 RB1CC1 ARFGEF3 CCDC88C SSH1 ZFP36L2 AMOT SRGAP1 CGN SSX2IP SEC16A NAV2 PHLDB2 KIF11 EXOC4 | 4.67e-07 | 1102 | 101 | 20 | int:YWHAH |
| Interaction | YWHAZ interactions | TLK2 DLG5 MYH11 COPB1 SPTA1 ANKRD26 LGR4 SIK3 RB1CC1 MYLK2 CCDC88C NCOR1 SSH1 ZFP36L2 SRGAP1 CGN SSX2IP NAV2 ATP2A2 GOLGA3 PHLDB2 KIF11 | 4.75e-07 | 1319 | 101 | 22 | int:YWHAZ |
| Interaction | CDC42 interactions | PMS1 ROCK2 EHBP1 DLG5 MYO1C SYNE1 ANKRD26 CASP7 RB1CC1 PREX2 DHX9 CFHR4 ARFGEF3 WDR91 MDN1 SRGAP1 MCM3AP CGN SSX2IP ZW10 TOP2B ARMC6 | 5.00e-07 | 1323 | 101 | 22 | int:CDC42 |
| Interaction | KRT27 interactions | 8.05e-07 | 202 | 101 | 9 | int:KRT27 | |
| Interaction | HAUS3 interactions | 8.60e-07 | 103 | 101 | 7 | int:HAUS3 | |
| Interaction | RCOR1 interactions | EHBP1 RANBP2 CENPF IKBKG SIN3A RB1CC1 SPDL1 NCOR1 BRCA2 AMOT SEC16A GOLGA3 EXOC4 | 1.13e-06 | 494 | 101 | 13 | int:RCOR1 |
| Interaction | PHF21A interactions | EHBP1 RANBP2 CENPF IKBKG RB1CC1 BRCA2 AMOT SEC16A EXOC1 GOLGA3 EXOC4 | 1.20e-06 | 343 | 101 | 11 | int:PHF21A |
| Interaction | PCM1 interactions | DLG5 CNTRL ANKRD26 RB1CC1 ODF2 SPDL1 CEP63 ODF2L HAUS4 SRGAP1 SSX2IP EXOC4 | 1.81e-06 | 434 | 101 | 12 | int:PCM1 |
| Interaction | KXD1 interactions | 2.26e-06 | 170 | 101 | 8 | int:KXD1 | |
| Interaction | ANAPC2 interactions | 2.72e-06 | 234 | 101 | 9 | int:ANAPC2 | |
| Interaction | CCDC138 interactions | 2.84e-06 | 123 | 101 | 7 | int:CCDC138 | |
| Interaction | YWHAG interactions | EHBP1 DLG5 COPB1 ANKRD26 LGR4 SIK3 RB1CC1 MYLK2 CCDC88C MDN1 SSH1 ZFP36L2 AMOT SRGAP1 CGN SSX2IP SEC16A NAV2 PHLDB2 EXOC4 | 3.20e-06 | 1248 | 101 | 20 | int:YWHAG |
| Interaction | CEP43 interactions | 5.15e-06 | 190 | 101 | 8 | int:CEP43 | |
| Interaction | KRT18 interactions | DLG5 KRT84 ANKRD26 IKBKG CASP7 RB1CC1 CEP63 ODF2L HAUS4 SSX2IP SEC16A | 8.17e-06 | 419 | 101 | 11 | int:KRT18 |
| Interaction | TBC1D31 interactions | 8.92e-06 | 56 | 101 | 5 | int:TBC1D31 | |
| Interaction | LATS1 interactions | DLG5 RNMT MYO1C ANKRD26 CCDC88C MDN1 AMOT CGN SSX2IP SEC16A KIF11 | 1.29e-05 | 440 | 101 | 11 | int:LATS1 |
| Interaction | NIN interactions | CNTRL ANKRD26 ODF2 CEP63 ARFGEF3 HAUS4 BRCA2 AMOT SSX2IP EXOC4 | 1.30e-05 | 359 | 101 | 10 | int:NIN |
| Interaction | HAUS4 interactions | 1.39e-05 | 104 | 101 | 6 | int:HAUS4 | |
| Interaction | KIAA0753 interactions | 1.42e-05 | 157 | 101 | 7 | int:KIAA0753 | |
| Interaction | ODF2 interactions | 1.48e-05 | 158 | 101 | 7 | int:ODF2 | |
| Interaction | SASS6 interactions | 1.54e-05 | 159 | 101 | 7 | int:SASS6 | |
| Interaction | TRIM37 interactions | DLG5 MYO1C COPB1 IKBKG TFAP2C DHX9 CEP63 NCOR1 MCM3AP SSX2IP SEC16A ATP2A2 PHLDB2 | 1.57e-05 | 630 | 101 | 13 | int:TRIM37 |
| Interaction | CCDC77 interactions | 1.73e-05 | 64 | 101 | 5 | int:CCDC77 | |
| Interaction | CFAP184 interactions | 1.74e-05 | 162 | 101 | 7 | int:CFAP184 | |
| Interaction | SIKE1 interactions | 1.86e-05 | 65 | 101 | 5 | int:SIKE1 | |
| Interaction | SNW1 interactions | ROCK2 RANBP2 COPB1 RB1 IKBKG WDR18 SIN3A ODF2 DHX9 NCOR1 MDN1 EXOC1 KIF11 EXOC4 | 2.12e-05 | 747 | 101 | 14 | int:SNW1 |
| Interaction | HAUS7 interactions | 2.47e-05 | 115 | 101 | 6 | int:HAUS7 | |
| Interaction | KRT38 interactions | 2.56e-05 | 172 | 101 | 7 | int:KRT38 | |
| Interaction | SLX4 interactions | PMS1 TLK2 RANBP2 WDR18 REV3L ODF2 SPDL1 DHX9 NCOR1 MDN1 BRCA2 ATP2A2 | 2.92e-05 | 572 | 101 | 12 | int:SLX4 |
| Interaction | TBK1 interactions | CNTRL IKBKG RB1CC1 ODF2 CEP63 TXLNB AMOT SSX2IP SEC16A GOLGA3 | 3.41e-05 | 402 | 101 | 10 | int:TBK1 |
| Interaction | WRAP73 interactions | 3.61e-05 | 123 | 101 | 6 | int:WRAP73 | |
| Interaction | GOLGA1 interactions | 3.80e-05 | 183 | 101 | 7 | int:GOLGA1 | |
| Interaction | SYCE1 interactions | 4.32e-05 | 127 | 101 | 6 | int:SYCE1 | |
| Interaction | HAUS8 interactions | 4.32e-05 | 127 | 101 | 6 | int:HAUS8 | |
| Interaction | NEFM interactions | 4.83e-05 | 190 | 101 | 7 | int:NEFM | |
| Interaction | CNTRL interactions | 5.33e-05 | 193 | 101 | 7 | int:CNTRL | |
| Interaction | KIAA1671 interactions | 5.51e-05 | 194 | 101 | 7 | int:KIAA1671 | |
| Interaction | OFD1 interactions | 6.23e-05 | 347 | 101 | 9 | int:OFD1 | |
| Interaction | HAUS5 interactions | 6.34e-05 | 136 | 101 | 6 | int:HAUS5 | |
| Interaction | DAXX interactions | 7.10e-05 | 353 | 101 | 9 | int:DAXX | |
| Interaction | CTDP1 interactions | 8.29e-05 | 207 | 101 | 7 | int:CTDP1 | |
| Interaction | TNRC6A interactions | 8.31e-05 | 280 | 101 | 8 | int:TNRC6A | |
| Interaction | HDAC4 interactions | RANBP2 SETD1B SIN3A REV3L PREX2 DHX9 NCOR1 CGN SSX2IP MYOCD CCDC136 TOP2B PHLDB2 | 8.72e-05 | 744 | 101 | 13 | int:HDAC4 |
| Interaction | TNRC6B interactions | 8.74e-05 | 282 | 101 | 8 | int:TNRC6B | |
| Interaction | SP1 interactions | 9.17e-05 | 365 | 101 | 9 | int:SP1 | |
| Interaction | KIF7 interactions | 9.39e-05 | 146 | 101 | 6 | int:KIF7 | |
| Interaction | CEP89 interactions | 9.75e-05 | 147 | 101 | 6 | int:CEP89 | |
| Interaction | TJP2 interactions | 1.01e-04 | 288 | 101 | 8 | int:TJP2 | |
| Interaction | AURKB interactions | DLG5 RANBP2 MYH11 MYO1C RB1 CNTRL WDR18 SIN3A DHX9 BRCA2 AMOT SEC16A ATP2A2 | 1.09e-04 | 761 | 101 | 13 | int:AURKB |
| Interaction | KCNA3 interactions | ROCK2 EHBP1 DLG5 RANBP2 MYO1C COPB1 ANKRD26 DHX9 CCDC88C CGN SEC16A ATP2A2 KIF11 EXOC4 | 1.11e-04 | 871 | 101 | 14 | int:KCNA3 |
| Interaction | MPHOSPH9 interactions | 1.16e-04 | 95 | 101 | 5 | int:MPHOSPH9 | |
| Interaction | MIB1 interactions | 1.19e-04 | 295 | 101 | 8 | int:MIB1 | |
| Interaction | HDAC1 interactions | MBD3L1 EHBP1 RANBP2 RB1 CENPF IKBKG SIN3A RB1CC1 ESCO1 SPDL1 NCOR1 BRCA2 AMOT GOLGA3 TOP2B EXOC4 | 1.21e-04 | 1108 | 101 | 16 | int:HDAC1 |
| Interaction | CSPP1 interactions | 1.22e-04 | 96 | 101 | 5 | int:CSPP1 | |
| Interaction | BRCA1 interactions | RNMT COPB1 RB1 CENPF ANKRD26 ODF2 TFAP2C BRAP DHX9 HOXA2 FBXO38 MDN1 BRCA2 SSX2IP SEC16A TOP2B KIF11 | 1.48e-04 | 1249 | 101 | 17 | int:BRCA1 |
| Interaction | NANOG interactions | RANBP2 CENPF WDR18 SIN3A RB1CC1 DHX9 NCOR1 MDN1 BRCA2 SEC16A | 1.51e-04 | 481 | 101 | 10 | int:NANOG |
| Interaction | SKI interactions | 1.55e-04 | 160 | 101 | 6 | int:SKI | |
| Interaction | CCHCR1 interactions | 1.55e-04 | 229 | 101 | 7 | int:CCHCR1 | |
| Interaction | HAUS6 interactions | 1.61e-04 | 161 | 101 | 6 | int:HAUS6 | |
| Interaction | RUBCN interactions | 1.91e-04 | 57 | 101 | 4 | int:RUBCN | |
| Interaction | DUSP16 interactions | 1.92e-04 | 237 | 101 | 7 | int:DUSP16 | |
| Interaction | PCNT interactions | 2.12e-04 | 241 | 101 | 7 | int:PCNT | |
| Interaction | PTEN interactions | RANBP2 RNMT MYO1C COPB1 SPTA1 SIN3A ITGA2 PREX2 DHX9 MDN1 AMOT SRGAP1 ATP2A2 KIF11 | 2.17e-04 | 929 | 101 | 14 | int:PTEN |
| Interaction | AGR2 interactions | MYH11 MYO1C COPB1 SPOCK1 SYNE1 SPTA1 CNTRL DHX9 EPG5 FSD1L CLEC4F MDN1 MYOCD ATP2A2 | 2.29e-04 | 934 | 101 | 14 | int:AGR2 |
| Interaction | EGLN3 interactions | RANBP2 MYO1C COPB1 CENPF EARS2 IKBKG SIK3 BRAP NCOR1 HAUS4 BRCA2 AMOT SSX2IP SEC16A ATP2A2 EXOC4 ARMC6 | 2.30e-04 | 1296 | 101 | 17 | int:EGLN3 |
| Interaction | TTK interactions | 2.37e-04 | 173 | 101 | 6 | int:TTK | |
| Interaction | SIPA1L1 interactions | 2.44e-04 | 174 | 101 | 6 | int:SIPA1L1 | |
| Interaction | LZTS2 interactions | 2.49e-04 | 512 | 101 | 10 | int:LZTS2 | |
| Interaction | RAC1 interactions | ROCK2 EHBP1 DLG5 ANKRD26 LGR4 CASP7 ITGA2 RB1CC1 PREX2 DHX9 MDN1 SRGAP1 MCM3AP ATP2A2 PHLDB2 | 2.59e-04 | 1063 | 101 | 15 | int:RAC1 |
| Interaction | ASF1A interactions | 2.59e-04 | 249 | 101 | 7 | int:ASF1A | |
| Interaction | PPP1R13B interactions | 2.60e-04 | 176 | 101 | 6 | int:PPP1R13B | |
| Interaction | WWTR1 interactions | 2.71e-04 | 422 | 101 | 9 | int:WWTR1 | |
| Interaction | PHLPP1 interactions | 2.72e-04 | 333 | 101 | 8 | int:PHLPP1 | |
| Interaction | SYCE3 interactions | 2.82e-04 | 63 | 101 | 4 | int:SYCE3 | |
| Interaction | LPXN interactions | 2.84e-04 | 115 | 101 | 5 | int:LPXN | |
| Interaction | CEP63 interactions | 2.85e-04 | 179 | 101 | 6 | int:CEP63 | |
| Interaction | GAN interactions | 2.85e-04 | 253 | 101 | 7 | int:GAN | |
| Interaction | STX4 interactions | 3.01e-04 | 428 | 101 | 9 | int:STX4 | |
| Interaction | NPM1 interactions | ROCK2 MYO1C COPB1 RB1 CENPF LGR4 WDR18 ZNF181 SPDL1 DHX9 CEP63 BRCA2 ZFP36L2 GOLGA3 TOP2B KIF11 | 3.02e-04 | 1201 | 101 | 16 | int:NPM1 |
| Interaction | DISC1 interactions | SYNE1 CEP63 ZHX1-C8orf76 AMOT C8orf76 EXOC1 FLACC1 CCDC136 EXOC4 | 3.06e-04 | 429 | 101 | 9 | int:DISC1 |
| Interaction | CWF19L2 interactions | 3.11e-04 | 182 | 101 | 6 | int:CWF19L2 | |
| Interaction | HAUS1 interactions | 3.21e-04 | 183 | 101 | 6 | int:HAUS1 | |
| Interaction | FBXO42 interactions | 3.29e-04 | 259 | 101 | 7 | int:FBXO42 | |
| Interaction | CDC5L interactions | PMS1 ROCK2 RANBP2 COPB1 SYNE1 WDR18 MYLK2 DHX9 MDN1 EXOC1 CCDC136 KIF11 EXOC4 | 3.41e-04 | 855 | 101 | 13 | int:CDC5L |
| Interaction | SMARCA2 interactions | 3.52e-04 | 346 | 101 | 8 | int:SMARCA2 | |
| Interaction | SYNC interactions | 3.58e-04 | 67 | 101 | 4 | int:SYNC | |
| Interaction | DPPA3 interactions | 3.58e-04 | 67 | 101 | 4 | int:DPPA3 | |
| Interaction | ENTR1 interactions | 3.70e-04 | 188 | 101 | 6 | int:ENTR1 | |
| Interaction | CENPF interactions | 3.73e-04 | 122 | 101 | 5 | int:CENPF | |
| Interaction | KRT8 interactions | 3.74e-04 | 441 | 101 | 9 | int:KRT8 | |
| Interaction | ATG14 interactions | 4.00e-04 | 69 | 101 | 4 | int:ATG14 | |
| Interaction | KDF1 interactions | 4.14e-04 | 192 | 101 | 6 | int:KDF1 | |
| GeneFamily | Exocyst complex | 4.23e-04 | 9 | 63 | 2 | 1055 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 ROCK2 MOK TLK2 EHBP1 RANBP2 GALNT1 RB1 CENPF SIK3 REV3L RB1CC1 MDN1 BRCA2 ZFP36L2 SOCS5 KIF11 | 3.33e-08 | 856 | 102 | 17 | M4500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | PMS1 NEMP1 CENPF CNTRL ANKRD26 SIN3A ANKRD36C ODF2 BRAP SPDL1 CEP63 ANKRD36B HAUS4 BRCA2 ZW10 KIF11 | 6.87e-07 | 939 | 102 | 16 | M45768 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 2.08e-06 | 466 | 102 | 11 | M13522 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | RANBP2 RB1 SPOCK1 SYNE1 REV3L RB1CC1 ODF2 DHX9 FBXO38 SSX2IP ARMC6 | 4.56e-06 | 506 | 102 | 11 | M253 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 1.86e-05 | 481 | 102 | 10 | M3898 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ROCK2 TLK2 RANBP2 CENPF ANKRD26 REV3L ODF2 NCOR1 ODF2L BRCA2 SRGAP1 TOP2B | 2.94e-08 | 311 | 101 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 MOK TLK2 RANBP2 RB1 CENPF ANKRD26 RB1CC1 ODF2 BRAP CEP63 NCOR1 ODF2L BRCA2 SRGAP1 GOLGA3 TOP2B EXOC4 | 6.79e-08 | 831 | 101 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ROCK2 TLK2 RANBP2 RB1 CENPF ANKRD26 REV3L ODF2 CEP63 CCDC88C NCOR1 ODF2L FSD1L BRCA2 SRGAP1 NAV2 TOP2B | 3.97e-06 | 989 | 101 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PMS1 ROCK2 MOK TLK2 TMEM67 RB1 CENPF CNTRL ANKRD26 REV3L ODF2 TFAP2C SPDL1 CCDC88C ODF2L FSD1L MDN1 BRCA2 KIF11 | 6.45e-06 | 1257 | 101 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ROCK2 RANBP2 CENPF ANKRD26 ODF2 ESCO1 PREX2 SPDL1 DHX9 CEP63 BRCA2 KIF11 | 8.51e-06 | 532 | 101 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PMS1 ROCK2 MOK TLK2 TMEM67 RB1 CENPF CNTRL ANKRD26 REV3L ODF2 TFAP2C PREX2 SPDL1 CCDC88C ODF2L FSD1L MDN1 BRCA2 KIF11 | 1.50e-05 | 1459 | 101 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_200 | 2.25e-05 | 35 | 101 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k2_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ROCK2 TLK2 TMEM67 RB1 CENPF CCDC186 CNTRL ANKRD26 WDR18 ODF2 TFAP2C PREX2 SPDL1 DHX9 MDN1 BRCA2 AMOT CPXM1 TOP2B | 5.58e-05 | 1468 | 101 | 19 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ROCK2 TLK2 TMEM67 RB1 CENPF CCDC186 CNTRL ANKRD26 WDR18 ODF2 SPDL1 DHX9 MDN1 BRCA2 AMOT CPXM1 TOP2B | 7.30e-05 | 1241 | 101 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | MORC1 PMS1 RB1 CENPF SIN3A TFAP2C SOHLH2 MDN1 BRCA2 SSX2IP ATF7IP2 ZW10 KIF11 | 1.01e-04 | 795 | 101 | 13 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 2.19e-04 | 255 | 101 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-09 | 176 | 103 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.99e-07 | 198 | 103 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.12e-07 | 199 | 103 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 178 | 103 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.18e-06 | 103 | 103 | 5 | 780a94c27ac3eb138a9f284251ae094d3e97ce71 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-06 | 184 | 103 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 190 | 103 | 6 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 190 | 103 | 6 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.33e-06 | 190 | 103 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 191 | 103 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 191 | 103 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-06 | 191 | 103 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.66e-06 | 192 | 103 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.83e-06 | 193 | 103 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.01e-06 | 194 | 103 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-06 | 195 | 103 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-06 | 195 | 103 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-06 | 197 | 103 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.75e-06 | 198 | 103 | 6 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 6.95e-06 | 199 | 103 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.95e-06 | 199 | 103 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.95e-06 | 199 | 103 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.98e-05 | 172 | 103 | 5 | ba36581ae339191a12a6d3ead39eaf69d78be10e | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.41e-05 | 175 | 103 | 5 | 6751ee4b312d7f87275f2c35e5878cfc3be3ebe3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.41e-05 | 175 | 103 | 5 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-05 | 178 | 103 | 5 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-05 | 182 | 103 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-05 | 182 | 103 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-05 | 182 | 103 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-05 | 184 | 103 | 5 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-05 | 186 | 103 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 186 | 103 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-05 | 186 | 103 | 5 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.40e-05 | 187 | 103 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.59e-05 | 188 | 103 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.59e-05 | 188 | 103 | 5 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 7.78e-05 | 189 | 103 | 5 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 7.78e-05 | 189 | 103 | 5 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 190 | 103 | 5 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Club|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.38e-05 | 192 | 103 | 5 | 044c7ae56da17cacf2705efa8ac2c8aeba6cfeee | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 8.59e-05 | 193 | 103 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 8.59e-05 | 193 | 103 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-05 | 194 | 103 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.80e-05 | 194 | 103 | 5 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.80e-05 | 194 | 103 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 8.80e-05 | 194 | 103 | 5 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-05 | 194 | 103 | 5 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-05 | 195 | 103 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-05 | 195 | 103 | 5 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-05 | 195 | 103 | 5 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.01e-05 | 195 | 103 | 5 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.23e-05 | 196 | 103 | 5 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 9.23e-05 | 196 | 103 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.23e-05 | 196 | 103 | 5 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.46e-05 | 197 | 103 | 5 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.46e-05 | 197 | 103 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-05 | 197 | 103 | 5 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-05 | 198 | 103 | 5 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-05 | 198 | 103 | 5 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 198 | 103 | 5 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 9.69e-05 | 198 | 103 | 5 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 9.92e-05 | 199 | 103 | 5 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 9.92e-05 | 199 | 103 | 5 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 9.92e-05 | 199 | 103 | 5 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 9.92e-05 | 199 | 103 | 5 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 9.92e-05 | 199 | 103 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 9.92e-05 | 199 | 103 | 5 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.92e-05 | 199 | 103 | 5 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 9.92e-05 | 199 | 103 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 103 | 5 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 103 | 5 | 54174a485a82480726fa06efa6e050ddea77cb3c | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 1.02e-04 | 200 | 103 | 5 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-04 | 128 | 103 | 4 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-04 | 132 | 103 | 4 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-04 | 132 | 103 | 4 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 133 | 103 | 4 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 133 | 103 | 4 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.80e-04 | 136 | 103 | 4 | d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 3.30e-04 | 142 | 103 | 4 | 319812c84fad93276bf093f2ad78db02ae745bf4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.06e-04 | 150 | 103 | 4 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.16e-04 | 151 | 103 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-04 | 151 | 103 | 4 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.49e-04 | 154 | 103 | 4 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | Epithelial-Epithelial-B_(AT1-AT2-progenitors)|Epithelial / shred on cell class and cell subclass (v4) | 4.49e-04 | 154 | 103 | 4 | 770712806e26f73456fb77a81aa4ef8ec78a21ea | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.82e-04 | 157 | 103 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.94e-04 | 158 | 103 | 4 | 4f3ea658e032555c2098d016475381c8d1071699 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.30e-04 | 161 | 103 | 4 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.30e-04 | 161 | 103 | 4 | 8ec923c230a7a3cce5edf2a736b3a00d607c698a | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.30e-04 | 161 | 103 | 4 | b19f82dd98a3064581793711bb70373f18abecd9 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.30e-04 | 161 | 103 | 4 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.30e-04 | 161 | 103 | 4 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.30e-04 | 161 | 103 | 4 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.43e-04 | 162 | 103 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.68e-04 | 164 | 103 | 4 | e24b06a14565f7798ac50c2fe3f34d4547b9000e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.68e-04 | 164 | 103 | 4 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.68e-04 | 164 | 103 | 4 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| Computational | Spindle and kinetochore. | 9.24e-05 | 16 | 61 | 3 | MODULE_315 | |
| Drug | ICI 182,780 | 4.07e-07 | 272 | 102 | 10 | CID000104741 | |
| Drug | Hoechst 33258 | 4.13e-06 | 94 | 102 | 6 | CID005326397 | |
| Drug | isobutyllithium | 1.02e-05 | 10 | 102 | 3 | CID000141200 | |
| Drug | AC1NSWD2 | 1.99e-05 | 2 | 102 | 2 | CID005318091 | |
| Drug | topsentin | 1.99e-05 | 2 | 102 | 2 | CID000072457 | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.31e-05 | 189 | 102 | 7 | 3788_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 5297_UP | |
| Drug | CP-645525-01 [287190-82-3]; Down 200; 10uM; PC3; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 7527_DN | |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 7290_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.01e-05 | 197 | 102 | 7 | 1048_UP | |
| Disease | cutaneous squamous cell carcinoma | 1.91e-04 | 33 | 100 | 3 | EFO_1001927 | |
| Disease | Fetal Cerebral Ventriculomegaly | 2.36e-04 | 7 | 100 | 2 | C2936718 | |
| Disease | Cerebral ventriculomegaly | 2.36e-04 | 7 | 100 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 2.36e-04 | 7 | 100 | 2 | C0270720 | |
| Disease | Post-Traumatic Hydrocephalus | 2.36e-04 | 7 | 100 | 2 | C0477432 | |
| Disease | Communicating Hydrocephalus | 2.36e-04 | 7 | 100 | 2 | C0009451 | |
| Disease | Obstructive Hydrocephalus | 2.36e-04 | 7 | 100 | 2 | C0549423 | |
| Disease | Aqueductal Stenosis | 3.14e-04 | 8 | 100 | 2 | C2936786 | |
| Disease | Congenital Hydrocephalus | 3.14e-04 | 8 | 100 | 2 | C0020256 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.67e-04 | 41 | 100 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.67e-04 | 41 | 100 | 3 | C0858252 | |
| Disease | Hydrocephalus | 4.03e-04 | 9 | 100 | 2 | C0020255 | |
| Disease | Mammary Carcinoma, Human | 4.23e-04 | 525 | 100 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.23e-04 | 525 | 100 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 4.34e-04 | 527 | 100 | 8 | C1458155 | |
| Disease | Breast Carcinoma | 4.97e-04 | 538 | 100 | 8 | C0678222 | |
| Disease | theophylline measurement | 5.03e-04 | 10 | 100 | 2 | EFO_0021180 | |
| Disease | forced expiratory volume, response to bronchodilator | 8.12e-04 | 445 | 100 | 7 | EFO_0004314, GO_0097366 | |
| Disease | Malignant neoplasm of breast | EHBP1 RB1 CENPF SYNE1 CASP7 SIK3 RB1CC1 EPG5 NCOR1 BRCA2 FLACC1 | 1.04e-03 | 1074 | 100 | 11 | C0006142 |
| Disease | Prostatic Neoplasms | 1.19e-03 | 616 | 100 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.19e-03 | 616 | 100 | 8 | C0376358 | |
| Disease | Neoplasms, Experimental | 1.48e-03 | 66 | 100 | 3 | C0027659 | |
| Disease | respiratory symptom change measurement, response to placebo | 1.50e-03 | 17 | 100 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | squamous cell carcinoma | 1.55e-03 | 67 | 100 | 3 | EFO_0000707 | |
| Disease | Microcephaly | 1.55e-03 | 67 | 100 | 3 | C0025958 | |
| Disease | Paroxysmal atrial fibrillation | 1.99e-03 | 156 | 100 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 1.99e-03 | 156 | 100 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.99e-03 | 156 | 100 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 2.18e-03 | 160 | 100 | 4 | C0004238 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 2.29e-03 | 21 | 100 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | BREAST CANCER | 2.29e-03 | 21 | 100 | 2 | 114480 | |
| Disease | blood pressure | 2.51e-03 | 22 | 100 | 2 | EFO_0004325 | |
| Disease | Cardiac Hypertrophy | 2.76e-03 | 82 | 100 | 3 | C1383860 | |
| Disease | Cardiomegaly | 2.76e-03 | 82 | 100 | 3 | C0018800 | |
| Disease | Neoplasm of the genitourinary tract | 2.99e-03 | 24 | 100 | 2 | cv:C0042065 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TEMCVRNIIQQLKNQ | 531 | Q13075 | |
| QCLNSEQTLRNEMKV | 2381 | Q9HCE0 | |
| QEMNKCLRANQVLLQ | 491 | Q7Z569 | |
| AQRMEQANKKCEEAR | 291 | Q7Z3E2 | |
| QCEQMKQTNINLESR | 626 | Q7Z3E2 | |
| MQQALVQLQAACEKR | 606 | Q4VCS5 | |
| KIEGIENMCNLQKLN | 161 | Q7Z7A1 | |
| AARKNMLLAAQQLCK | 346 | Q92754 | |
| QQCKEMIKTQQQLLQ | 391 | Q9Y2D8 | |
| QKAGVQKQACMLIRN | 426 | Q6NXE6 | |
| RKLMKQVQEQCPNIT | 306 | Q96SM3 | |
| ERFCQLKKQNMLLQQ | 1156 | Q8N2N9 | |
| NENRTALMKAVQCQE | 111 | Q9UPS8 | |
| RVQKDLSQTQCQMKE | 1096 | Q9UPS8 | |
| QRIKMNKCDEQEQIS | 416 | Q6DHV5 | |
| MKLENCVQANKTIQN | 541 | A6NI56 | |
| QKINQMVCNSDRVLK | 846 | P06400 | |
| NQKRMICNIISLEDN | 281 | P55895 | |
| TFEECQQNLMKLQKG | 3036 | P49792 | |
| IQLKCENLQQKLEQM | 526 | Q9ULJ1 | |
| NQEKQELCNDVLAMK | 751 | Q86VD1 | |
| QKNEKALTNIQNCMA | 236 | Q96K31 | |
| ERFCQLKKQNMLLQQ | 1581 | Q5JPF3 | |
| MAKSSQRKQRDCVNQ | 1 | Q8WWY6 | |
| ECRQTIAKLDNQNMK | 346 | Q8TDY2 | |
| ECALQQAKQDMARQL | 431 | Q9NSB2 | |
| MQRLNNKINSYCKAE | 2181 | Q9NU22 | |
| LRCAEMKQNFENKNR | 161 | Q96Q35 | |
| SMINCIKQEQARKSQ | 96 | Q9BXM9 | |
| MDNKNELDQCKSDLQ | 441 | P52732 | |
| DAKINNENMTKCLQS | 771 | O60318 | |
| QMLKKECETLRQNQG | 1001 | Q9P219 | |
| IVKDQRARMNAAQCL | 521 | Q9H1R3 | |
| MLQESQVCEKRASQQ | 51 | O14524 | |
| LTAKNEMNCKEDQFQ | 676 | P53618 | |
| QCRREGFSQKMQEQK | 181 | Q9Y282 | |
| ICTQILAMVNQEQNK | 1896 | Q8TDM6 | |
| CQQQMAEDKASVKAQ | 131 | Q9Y6K9 | |
| NNLCQEQKMLRTLDL | 336 | Q9BXB1 | |
| CDNLRNRKNEILEMN | 326 | Q9NSB4 | |
| ACKQMKQRFESIEQV | 31 | Q9UQ07 | |
| KNLNSCLQQLKQEMD | 1426 | Q08378 | |
| CLQQLKQEMDSLQRQ | 1431 | Q08378 | |
| LFKENNERCLQKNMV | 716 | P17301 | |
| RMQLQKQKRNNCSEK | 546 | Q8IZQ8 | |
| AQCKKLNMDQVLDQI | 976 | Q6PIJ6 | |
| VTNENSNCEMRKEKR | 231 | O95389 | |
| NVETNQCLDNMARKE | 436 | Q10472 | |
| GIKKMCRNIFVLQQN | 866 | Q96A65 | |
| ERANACNSVIKQLMK | 466 | P16615 | |
| KNIPMEKNQDVCALN | 811 | P51587 | |
| CKEMQNSLNNDKNLV | 1591 | P51587 | |
| SQKQMNSDLQKQCEE | 841 | P49454 | |
| GFKILNCQKAMEERQ | 306 | Q9BTV6 | |
| QLEISTQMCKKQNDR | 526 | Q96MT8 | |
| KEQNQKERDAICMSL | 901 | Q5TH69 | |
| NMNFEKLGKCIIINN | 61 | P55210 | |
| CIITEENMNKNNIQL | 516 | Q92496 | |
| DQDDCIKQANMRSAK | 226 | Q8NDI1 | |
| SCRKQVEMLNKSRNV | 21 | Q5U623 | |
| VSVKQCQQRYEDMKN | 231 | O43148 | |
| RNITCQQEKMKEINS | 446 | Q5FWF5 | |
| NFDKCISNQIRQMEE | 646 | Q9NV70 | |
| QQCQDAKSQQKEQML | 211 | Q9H6D7 | |
| PEQMNLNEDSCNKKS | 536 | P54277 | |
| VGNKNRQKFMCEVQV | 26 | Q08211 | |
| KEAENSRLCMQIKNL | 356 | Q5BJF6 | |
| MKHKRQTQCKENQNS | 196 | O43364 | |
| NMNLKREAENLCSQR | 806 | Q5HYA8 | |
| QQKCLEQQTEMRVQL | 31 | Q7Z6B7 | |
| VNAADNKQRDKNMTC | 111 | Q02880 | |
| DMNSNRCLSVKEKNI | 31 | O75159 | |
| QDRCLNMQEKVKTNG | 5301 | Q8NF91 | |
| KQREQKICQRYDQLM | 301 | O75376 | |
| KNRSQMIENIDACLN | 141 | Q8IVL1 | |
| ELQNQLDKCRNEMMT | 36 | Q96EA4 | |
| QRKAEQLMSDENCFK | 1051 | Q96ST3 | |
| KMGNNSSIKQLQQEC | 641 | Q9Y2K2 | |
| NDNIRENFLRDMCKK | 111 | Q9UPS6 | |
| ELQRKDQLQQKIMCP | 66 | Q9BV38 | |
| NNLIMMLQREKENLC | 791 | Q86SQ0 | |
| RCRNMSQEQVAQKLA | 166 | Q5JPH6 | |
| IRNELEKQMNCNLKE | 276 | Q8WYL5 | |
| ANCDLRRQIDEQQKM | 241 | Q86UE8 | |
| MQEEQKKLIQNQDCV | 621 | Q96JN2 | |
| QQLRQDCEEASKAKM | 691 | Q9P2M7 | |
| IQMLKCRVDNVNSQL | 121 | Q8N1N0 | |
| CQDQEQKVEMTSKQQ | 6 | Q6X4T0 | |
| QQLTAMKVIQRNCAA | 811 | P35749 | |
| KSSQMQSEPQKERNC | 771 | A4D1E1 | |
| QRQCMKLLEGKASIQ | 2891 | O60673 | |
| QNKAMKCLQNENLID | 1516 | O15027 | |
| INQDIKCQLMKEVQR | 531 | A6NJ88 | |
| NMIFRNVNLKQAEVC | 56 | Q6ZNM6 | |
| LPCQNEMNRIQKLSK | 311 | Q08629 | |
| QKRCLTQNDLKMQTQ | 801 | O75116 | |
| AVCSNINEAKRQMEK | 206 | Q70Z35 | |
| QKEEARQVKNFEMCQ | 2146 | P02549 | |
| QRNLKTNICLKNMAS | 61 | A0A3B3IT33 | |
| KCNKLESQQENQRMG | 191 | Q9UJL9 | |
| IEQQSERNMKLCQEN | 261 | Q8N3L3 | |
| EALQSNMRFCKKQQT | 266 | Q9NX45 | |
| EFSELKQMLVQQRNC | 431 | Q9ULD5 | |
| CKTEKSLANLNLNNM | 16 | P47974 | |
| EAKKNLCEININDNM | 481 | A4D1P6 | |
| NEKALTNIQNCMAEK | 206 | Q96EF9 | |
| QKCRKSFNQLESLNM | 436 | Q2M3W8 | |
| NKKCQDVIVAARNLM | 401 | O43264 | |
| KNNDLLFRNLKETMC | 561 | O00159 |